Tae W. Kang

Seoul, Republic of Korea

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 188 publications

An artificial intelligence model integrating clinico-laboratory data and single nucleotide polymorphism-based genomic risk for prostate cancer diagnosis in Korean men.

An artificial intelligence model integrating clinico-laboratory data and single nucleotide polymorphism-based genomic risk for prostate cancer diagnosis in Korean men.

Journal: Investigative and clinical urology
Published: January 01, 2026

Prognostic factors in first-line atezolizumab-bevacizumab treatment of intermediate or advanced hepatocellular carcinoma.

Prognostic factors in first-line atezolizumab-bevacizumab treatment of intermediate or advanced hepatocellular carcinoma.

Journal: PloS one
Published: October 16, 2025

Prospective evaluation of the safety and efficacy of microwave ablation for hepatocellular carcinoma in Korean patients.

Prospective evaluation of the safety and efficacy of microwave ablation for hepatocellular carcinoma in Korean patients.

Journal: Ultrasonography (Seoul, Korea)
Published: September 10, 2025

Prenatal computed tomography (CT) and risk of congenital heart disease and cerebral palsy: A nationwide mother-child paired cohort study.

Prenatal computed tomography (CT) and risk of congenital heart disease and cerebral palsy: A nationwide mother-child paired cohort study.

Journal: BMC medicine
Published: August 08, 2025

Comparison of ultrasound-detected and undetected hepatocellular carcinomas: a post-hoc, subgroup analysis from the MAGNUS-HCC surveillance trial.

Comparison of ultrasound-detected and undetected hepatocellular carcinomas: a post-hoc, subgroup analysis from the MAGNUS-HCC surveillance trial.

Journal: Ultrasonography (Seoul, Korea)
Published: July 31, 2025

Development of PdO/Sr3Fe2O7-δ /α-Al2O3 catalysts for methane combustion.

Development of PdO/Sr3Fe2O7-δ /α-Al2O3 catalysts for methane combustion.

Journal: RSC advances
Published: April 24, 2025

Percutaneous radiofrequency ablation of hepatocellular carcinomas abutting the right posterior diaphragm: factors associated with tumor recurrence and overall survival.

Percutaneous radiofrequency ablation of hepatocellular carcinomas abutting the right posterior diaphragm: factors associated with tumor recurrence and overall survival.

Journal: Acta radiologica (Stockholm, Sweden : 1987)
Published: November 27, 2024

Gastrointestinal tract perforation after radiofrequency ablation for hepatic tumor: Incidence and risk factors.

Gastrointestinal tract perforation after radiofrequency ablation for hepatic tumor: Incidence and risk factors.

Journal: European journal of radiology
Published: December 24, 2023

Correction to: Consensus report from the 10th Global Forum for Liver Magnetic Resonance Imaging: developments in HCC management.

Correction to: Consensus report from the 10th Global Forum for Liver Magnetic Resonance Imaging: developments in HCC management.

Journal: European radiology
Published: December 19, 2023

Comparison of non-contrast abbreviated MRI and ultrasound as surveillance modalities for HCC.

Comparison of non-contrast abbreviated MRI and ultrasound as surveillance modalities for HCC.

Journal: Journal of hepatology
Published: November 30, 2023

Ultrasonographic findings of metabolic dysfunction-associated fatty liver disease: A comparative study with non-alcoholic fatty liver disease and clinical characteristics.

Ultrasonographic findings of metabolic dysfunction-associated fatty liver disease: A comparative study with non-alcoholic fatty liver disease and clinical characteristics.

Journal: Clinical imaging
Published: November 18, 2023

Value of Sonazoid-enhanced ultrasonography in characterizing indeterminate focal liver lesions on gadoxetic acid-enhanced liver MRI in patients without risk factors for hepatocellular carcinoma.

Value of Sonazoid-enhanced ultrasonography in characterizing indeterminate focal liver lesions on gadoxetic acid-enhanced liver MRI in patients without risk factors for hepatocellular carcinoma.

Journal: PloS one
Published: November 15, 2023
Showing 1-12 of 188

Last Updated: 09/26/2026